Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)

被引:0
作者
Laurent Desjardins
Audrey Dionne
Léamarie Meloche-Dumas
Anne Fournier
Nagib Dahdah
机构
[1] Université de Montréal,Division of Pediatric Cardiology, CHU Mère
[2] Dalhousie University,Enfant Ste
[3] Harvard Medical School,Justine
来源
Pediatric Cardiology | 2020年 / 41卷
关键词
Kawasaki disease; Vasculitis; NTpro-BNP; Biomarker; Systolic and diastolic function;
D O I
暂无
中图分类号
学科分类号
摘要
The N-terminal proBNP (NT-proBNP), produced by cardiomyocytes, has several reported utilities and associations in acute Kawasaki disease (KD). The objective of this study is to examine the relationship between serum values of NT-proBNP at time of KD diagnosis with cardiac systolic, diastolic function and electrocardiographic changes, at onset of the disease and during the first year of follow-up. KD was diagnosed in 127 children between March 2007 and July 2014, mean diagnostic age 3.5 ± 2.9 years. Coronary artery maximum z score was 2.6 ± 2.8 (range − 0.6 to + 18.9), with giant aneurysm in 5/122 (4.1%). Age-adjusted NT-proBNP was 2.6 ± 1.6 z score, 78/122 (63.9%) > 2.0. There was a crescendo correlation between onset NT-proBNP z score and C-Reactive protein (CRP) serum levels (slope + 0.49, p < 0.001). There was a crescendo correlation between NT-proBNP z score and indexed left ventricular (LV) mass (slope + 1.86, p = 0.02), LV diastolic function parameter E/e′ ratio (slope + 0.31, p = 0.04) and a decrescendo correlation with age-adjusted LV shortening fraction (SF) (− 0.63, p = 0.02). Lower SF z score, higher left ventricular mass index and E/e′ ratio were associated with higher NT-proBNP z score, but without correlation with CRP levels. Within 2–3 months from the onset of the disease, there was a resolution of the systolic dysfunction. Electrocardiographic parameter changes were associated with decreased LV shortening fraction but not with NT-proBNP. KD patients with elevated NT-proBNP at onset have sub-clinical myocardial involvement and might benefit from follow-up and continued evaluation, even in the absence of coronary artery involvement.
引用
收藏
页码:947 / 954
页数:7
相关论文
共 288 条
[41]  
Spigelblatt L(2010)Sudden death related myocarditis: a study of 56 cases Forensic Sci Med Pathol 6 13-undefined
[42]  
Saint-Cyr C(1986)Sudden cardiac death in Air Force recruits. A 20-year review JAMA 256 2696-undefined
[43]  
Mir TS(2012)Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery J Am Coll Cardiol 59 1604-undefined
[44]  
Nir A(2015)Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology Circulation 132 e273-undefined
[45]  
Dallaire F(undefined)undefined undefined undefined undefined-undefined
[46]  
Cousineau J(undefined)undefined undefined undefined undefined-undefined
[47]  
Delvin E(undefined)undefined undefined undefined undefined-undefined
[48]  
Dahdah N(undefined)undefined undefined undefined undefined-undefined
[49]  
Adjagba PM(undefined)undefined undefined undefined undefined-undefined
[50]  
Desjardins L(undefined)undefined undefined undefined undefined-undefined